切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (04) : 292 -296. doi: 10.3877/cma.j.issn.2095-3224.2016.04.003

所属专题: 文献

专家论坛

精准医疗时代低位直肠癌选择性侧方淋巴结清扫价值与策略
王海江1,(), 葛磊1   
  1. 1. 830011 新疆医科大学附属肿瘤医院胃肠外科
  • 收稿日期:2016-03-21 出版日期:2016-08-25
  • 通信作者: 王海江
  • 基金资助:
    国家自然科学基金资助项目(No.81560385)

Strategies and value of the treatment of lateral lymphnode dissection for low rectal cancer in the era of precision medicine

Haijiang Wang1,(), Lei Ge1   

  1. 1. Department of Gastrointestinal Surgery, Xinjiang Medical University Affiliated Tumor Hospital. Xinjiang 830011, China
  • Received:2016-03-21 Published:2016-08-25
  • Corresponding author: Haijiang Wang
  • About author:
    Corresponding author: Wang Haijiang, Email:
引用本文:

王海江, 葛磊. 精准医疗时代低位直肠癌选择性侧方淋巴结清扫价值与策略[J]. 中华结直肠疾病电子杂志, 2016, 05(04): 292-296.

Haijiang Wang, Lei Ge. Strategies and value of the treatment of lateral lymphnode dissection for low rectal cancer in the era of precision medicine[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(04): 292-296.

随着生物分析技术、基因测序以及大数据分析工具的出现,医学进入了精准医疗时代。临床影像等技术的进步和发展,肿瘤患者术前精准临床分期判断及分子生物学信息的获得使得个体化的精准医疗成为可能,精准医疗时代对直肠癌的诊治提出了新的要求,不同部位的直肠癌治疗方案亦有所差异。手术治疗仍然是当今治疗直肠癌的主要方式,对于侧方淋巴结清扫问题一直存有争议,究其原因侧方淋巴结转移(lateral pelvic lymph node metastasis,LPLM)是全身系统性转移还是局部转移。笔者认为,低位直肠癌诊治应在充分推广诊疗规范的基础上,通过对数据的分析,筛选行侧方淋巴结手术治疗的获益人群,根据精确的诊断分期控制手术指征与范围,减少不必要的创伤及过度治疗从而真正实现精准医疗。

With the emergency of biological technology, gene sequencing and big data analysis tools, medical treatment entered the era of precision medical. As a result of the progress and development of clinical imaging techniques, the acquisition of clinical and personal biological data has made personalized treatment possible. The era of precision medicine has brought new horizon for diagnosis and treatment of rectal cancer. Different treatment should be taken into account in a different location in rectal cancer. Surgery is still considered as the principal treatment for rectal cancer, however, there is long-standing controversy as to whether LPN metastases represent systemic or localized disease. Based on the promotion of standard treatment for rectal cancer, we must share following views that the different subjects should join forces to improve selection criteria for LPND, avoid unnecessary injury, prevent over treatment, and ultimately aim to propose the precision medicine program in the future for patients with low rectal cancer.

[1]
Gerota. Die Lymphgefasse des Rectums und des Anus[J]. Arch Anat Physiol, 1895, 240.
[2]
Senba Y. An anatomical study of lymphatic system of the rectum (in Japanese)[J]. J Hukuoka Med Coll, 1927, 20:1213-1268.
[3]
Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis[J]. Am J Surg, 1951, 81(1):111-120.
[4]
Stearns MW, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum[J]. Dis Colon Rectum, 1959, 2(2):169-172.
[5]
Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer[J]. Dis Colon Rectum, 2006, 49(11):1663-1672.
[6]
Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease[J]? Ann Surg, 2012, 255(6):1129-1134.
[7]
Nakamura T, Watanabe M. Lateral lymph node dissection for lower rectal cancer[J]. World J Surg, 2013, 37(8):1808-1813.
[8]
Fujita S, Yamamoto S, Akasu T, et al. Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer[J]. Int J Colorectal Dis, 2009, 24(9):1085-1090.
[9]
Nagayoshi K, Ueki T, Manabe T, et al. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach[J]. Surg Endosc, 2016, 30(5):1938-1947.
[10]
王海江,赵泽亮,杨新辉, 等. 中低位直肠癌侧方淋巴结转移的危险因素分析[J]. 中华胃肠外科杂志, 2012, 15(10):1062-1065.
[11]
LeBlanc JK. Imaging and management of rectal cancer[J]. Nat Clin Pract Gastroenterol Hepatol, 2007, 4(12):665-676.
[12]
Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer[J]. World J Surg, 2011, 35(4):895-899.
[13]
Matsuoka H, Nakamura A, Masaki T, et al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma[J]. Anticancer Res, 2007, 27(5B):3529-3533.
[14]
Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison[J]. Radiology, 2003, 227(2):371-377.
[15]
Ogawa S, Itabashi M, Hirosawa T, et al. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI[J]. J Surg Oncol, 2014, 109(3):227-233.
[16]
Ishibe A, Ota M, Watanabe J, et al. Prediction of Lateral Pelvic Lymph-Node Metastasis in Low Rectal Cancer by Magnetic Resonance Imaging[J]. World J Surg, 2016, 40(4):995-1001.
[17]
Engelen SME, Maas M, Lahaye MJ, et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge[J]. Eur J Cancer, 2013, 49(10):2311-2320.
[18]
Kanamoto T, Matsuki M, Okuda J, et al. Preoperative evaluation of local invasion and metastatic lymph nodes of colorectal cancer and mesenteric vascular variations using multidetector-row computed tomography before laparoscopic surgery[J]. J Comput Assist Tomogr, 2007, 31(6):831-839.
[19]
Kobayashi H, Kikuchi A, Okazaki S, et al. Diagnostic performance of multidetector row computed tomography for assessment of lymph node metastasis in patients with distal rectal cancer[J]. Ann Surg Oncol, 2015, 22(1):203-208.
[20]
Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis[J]. Lancet Oncol, 2009, 10(11):1053-1062.
[21]
Akiyoshi T, Ueno M, Matsueda K, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging[J]. Ann Surg Oncol, 2014, 21(1):189-196.
[22]
Yokoyama S, Takifuji K, Hotta T, et al. Survival benefit of lateral lymph node dissection according to the region of involvement and the number of lateral lymph nodes involved[J]. Surg Today, 2014, 44(6):1097-1103.
[23]
Kusters M, Beets GL, van de Velde CJH, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence[J]. Ann Surg, 2009, 249(2):229-235.
[24]
Watanabe T, Tsurita G, Muto T, et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers[J]. Surgery, 2002, 132(1):27-33.
[25]
Kim TH, Jeong S-Y, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection[J]. Ann Surg Oncol, 2008, 15(3):729-737.
[26]
Otowa Y, Yamashita K, Kanemitsu K, et al. Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging[J]. OncoTargets Ther, 2015, 8:3169-3173.
[27]
Liang JT. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after concurrent chemoradiation therapy[J]. Ann Surg Oncol, 2011, 18(1):153-159.
[28]
董新舒,徐海涛,李志高, 等. 直肠癌保肛手术中侧方清扫保留盆腔自主神经124例的疗效评价[J]. 中华外科杂志,2007,45(17):1164-1166.
[29]
刘宝善,燕锦,左明, 等. 直肠癌侧方淋巴结清扫的效果分析[J]. 中华外科杂志,2004,42(15):908-910.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[3] 刘林峰, 王增涛, 王云鹏, 钟硕, 郝丽文, 仇申强, 陈超. 足底内侧皮瓣联合甲骨皮瓣在手指V度缺损再造中的临床应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 480-484.
[4] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[5] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[6] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[8] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[9] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[10] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[11] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[12] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[13] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[14] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[15] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
阅读次数
全文


摘要